Biological control networks suggest the use of biomimetic sets for combinatorial therapies

Abstract

Cells are regulated by networks of controllers having many targets, and targets affected by many controllers, but these "many-to-many" combinatorial control systems are poorly understood. Here we analyze distinct cellular networks (transcription factors, microRNAs, and protein kinases) and a drug-target network. Certain network properties seem universal across systems and species, suggesting the existence of common control strategies in biology. The number of controllers is ~8% of targets and the density of links is 2.5% \pm 1.2%. Links per node are predominantly exponentially distributed, implying conservation of the average, which we explain using a mathematical model of robustness in control networks. These findings suggest that optimal pharmacological strategies may benefit from a similar, many-to-many combinatorial structure, and molecular tools are available to test this approach.

33 pages

References in corpus (3)

• Catastrophic cascade of failures in interdependent networks
• Systems approaches and algorithms for discovery of combinatorial therapies
• Function Constrains Network Architecture and Dynamics: A Case Study on the Yeast Cell Cycle Boolean Network

Cited by in corpus (4)

• Control of asymmetric Hopfield networks and application to cancer attractors
• Prediction of kinase inhibitor response using activity profiling, in-vitro screening, and elastic net regression
• A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia
• Multi-species network inference improves gene regulatory network reconstruction for early embryonic development in Drosophila